spacer
spacer

PDBsum entry 3c8b

Go to PDB code: 
protein ligands metals links
Hydrolase/hydrolase inhibitor PDB id
3c8b

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
423 a.a. *
Ligands
ARG-ARG-GLY-ILE-
NH2
SO4 ×3
Metals
_ZN
Waters ×372
* Residue conservation analysis
PDB id:
3c8b
Name: Hydrolase/hydrolase inhibitor
Title: Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with inhibitory peptide rrgi
Structure: Botulinum neurotoxin a light chain. Chain: a. Fragment: residues 1-424. Synonym: bontoxilysin-a. Engineered: yes. Inhibitor peptide rrgi. Chain: b. Engineered: yes
Source: Clostridium botulinum. Organism_taxid: 1491. Strain: hall. Atcc: 3502. Gene: bota. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Synthetic construct.
Resolution:
1.47Å     R-factor:   0.204     R-free:   0.216
Authors: D.Kumaran,S.Swaminathan
Key ref:
D.Kumaran et al. (2008). Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A. J Biol Chem, 283, 18883-18891. PubMed id: 18434312 DOI: 10.1074/jbc.M801240200
Date:
11-Feb-08     Release date:   22-Apr-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P0DPI1  (BXA1_CLOBH) -  Botulinum neurotoxin type A from Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1296 a.a.
423 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.24.69  - bontoxilysin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
      Cofactor: Zn(2+)

 

 
DOI no: 10.1074/jbc.M801240200 J Biol Chem 283:18883-18891 (2008)
PubMed id: 18434312  
 
 
Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A.
D.Kumaran, R.Rawat, M.L.Ludivico, S.A.Ahmed, S.Swaminathan.
 
  ABSTRACT  
 
The seven antigenically distinct serotypes of Clostridium botulinum neurotoxins cleave specific soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex proteins and block the release of neurotransmitters that cause flaccid paralysis and are considered potential bioweapons. Botulinum neurotoxin type A is the most potent among the clostridial neurotoxins, and to date there is no post-exposure therapeutic intervention available. To develop inhibitors leading to drug design, it is imperative that critical interactions between the enzyme and the substrate near the active site are known. Although enzyme-substrate interactions at exosites away from the active site are mapped in detail for botulinum neurotoxin type A, information about the active site interactions is lacking. Here, we present the crystal structures of botulinum neurotoxin type A catalytic domain in complex with four inhibitory substrate analog tetrapeptides, viz. RRGC, RRGL, RRGI, and RRGM at resolutions of 1.6-1.8 A. These structures show for the first time the interactions between the substrate and enzyme at the active site and delineate residues important for substrate stabilization and catalytic activity. We show that OH of Tyr(366) and NH(2) of Arg(363) are hydrogen-bonded to carbonyl oxygens of P1 and P1' of the substrate analog and position it for catalytic activity. Most importantly, the nucleophilic water is replaced by the amino group of the N-terminal residue of the tetrapeptide. Furthermore, the S1' site is formed by Phe(194), Thr(215), Thr(220), Asp(370), and Arg(363). The K(i) of the best inhibitory tetrapeptide is 157 nm.
 
  Selected figure(s)  
 
Figure 4.
FIGURE 4. Schematic diagram of molecular interactions between Balc424 and tetrapeptide inhibitors. The interactions between Balc424 active site residues and inhibitor peptides are shown. A, RRGC; B, RRGM; C, RRGL; and D, RRGI. Black, red, blue, yellow, and green colored circles represent carbon, oxygen, nitrogen, sulfur, and sodium atoms, respectively. For clarity, zinc coordination and water molecules involved in the interactions at the active site are not shown. The figure was prepared with Ligplot (47).
Figure 7.
FIGURE 7. Electrostatic potential surface representation of active site cavity. Models of RRGC (green), RRGM (light green), RRGL (coral), and RRGI (magenta) with sulfate ions are superposed. Red and blue indicate negative ( -0.5 V) and positive ( +0.5 V) electrostatic potential. The figure was prepared with CCP4MG (50). The orientation is similar to Fig. 3A.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2008, 283, 18883-18891) copyright 2008.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20155918 B.Li, R.Pai, S.C.Cardinale, M.M.Butler, N.P.Peet, D.T.Moir, S.Bavari, and T.L.Bowlin (2010).
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
  J Med Chem, 53, 2264-2276.  
20614028 J.E.Zuniga, J.T.Hammill, O.Drory, J.E.Nuss, J.C.Burnett, R.Gussio, P.Wipf, S.Bavari, and A.T.Brunger (2010).
Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.
  PLoS One, 5, e11378.
PDB code: 3nf3
20877571 N.Gul, L.A.Smith, and S.A.Ahmed (2010).
Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.
  PLoS One, 5, e12872.  
  21149997 R.K.Dhaked, M.K.Singh, P.Singh, and P.Gupta (2010).
Botulinum toxin: bioweapon & magic drug.
  Indian J Med Res, 132, 489-503.  
19226630 S.I.Toth, L.A.Smith, and S.A.Ahmed (2009).
Extreme sensitivity of botulinum neurotoxin domains towards mild agitation.
  J Pharm Sci, 98, 3302-3311.  
19695105 T.Xu, L.Zhang, X.Wang, D.Wei, and T.Li (2009).
Structure-based substrate screening for an enzyme.
  BMC Bioinformatics, 10, 257.  
18818739 D.Kumaran, R.Rawat, S.A.Ahmed, and S.Swaminathan (2008).
Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
  PLoS Pathog, 4, e1000165.
PDB codes: 3dda 3ddb
18658150 R.Agarwal, and S.Swaminathan (2008).
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
  J Biol Chem, 283, 25944-25951.
PDB code: 3d3x
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer